Directing R&D (and therefore intangible asset creation) need not be revelationary or reactionary.
Read MoreTechnology rights alone are often insufficient to develop a mainstream consumer market upon – design rights and eventually branding are required to take innovation to the next level.
Read MoreWhat members have to say about the value in joining ExportNZ.
Read MorePolitical analysis, news of the world and intelligent talk-back feature in Leighton Smith’s weekday show.
Read MoreA “see no evil, hear no evil” approach to Freedom to Operate (FTO) has left some New Zealand companies badly burnt. Here are 4 key points to keep in mind.
Read MoreA national airline developed a clever technology designed to set it apart from competitors but wasn’t sure how best to commercialize it. EverEdge quickly helped it to determine the best way forward – saving them a six-figure sum in the process.
Read MoreEverEdge assisted a major NZ Technology Transfer Office (TTO) on a biotechnology licensing case against a tight deadline. The advice provided on the client’s intellectual property position and the critical terms for the license meant the TTO was one step ahead…
Read MoreArticle originally published in the Australian Private Equity and Venture Capital Journal. It is a subscription publication. To ensure you receive 11 issues a year, subscribe at www.privateequitymedia.com.au .
Read MoreWho are we? What are your intangible assets and how much are they worth?
This video introduces EverEdge and how we can help you generate value from your data, code, brand, know-how, patents, copyright, trade secrets, design, domains, approvals, plant rights and systems.